- Home
- YMAB vs LGI Comparison
YMAB vs LGI Comparison
Compare YMAB & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- LGI
- Stock Information
- Founded
- YMAB 2015
- LGI 2004
- Country
- YMAB United States
- LGI United States
- Employees
- YMAB N/A
- LGI N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- LGI
- Sector
- YMAB Health Care
- LGI
- Exchange
- YMAB Nasdaq
- LGI Nasdaq
- Market Cap
- YMAB 192.4M
- LGI 210.5M
- IPO Year
- YMAB 2018
- LGI N/A
- Fundamental
- Price
- YMAB $4.36
- LGI $16.81
- Analyst Decision
- YMAB Buy
- LGI
- Analyst Count
- YMAB 11
- LGI 0
- Target Price
- YMAB $17.55
- LGI N/A
- AVG Volume (30 Days)
- YMAB 202.0K
- LGI 41.1K
- Earning Date
- YMAB 08-11-2025
- LGI 01-01-0001
- Dividend Yield
- YMAB N/A
- LGI 7.10%
- EPS Growth
- YMAB N/A
- LGI N/A
- EPS
- YMAB N/A
- LGI N/A
- Revenue
- YMAB $88,658,000.00
- LGI N/A
- Revenue This Year
- YMAB N/A
- LGI N/A
- Revenue Next Year
- YMAB $15.15
- LGI N/A
- P/E Ratio
- YMAB N/A
- LGI N/A
- Revenue Growth
- YMAB 4.92
- LGI N/A
- 52 Week Low
- YMAB $3.55
- LGI $12.66
- 52 Week High
- YMAB $16.11
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- YMAB 45.29
- LGI 59.81
- Support Level
- YMAB $4.10
- LGI $16.77
- Resistance Level
- YMAB $4.62
- LGI $17.03
- Average True Range (ATR)
- YMAB 0.29
- LGI 0.17
- MACD
- YMAB -0.04
- LGI -0.00
- Stochastic Oscillator
- YMAB 20.73
- LGI 76.36
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.